Inventor

Michael Brines

Inventor

Woodbridge, CT, US

Overview

2003–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes33%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%

C07KPeptides20%

Y02ATechnologies for adaptation to climate change10%

A61LMethods or apparatus for sterilising materials or objects in general2%

A61QSpecific use of cosmetics or similar toiletry preparations2%

C12NMicroorganisms or enzymes2%

G01NInvestigating or analysing materials by determining their chemical or physical properties2%

PatentTitleYear

10,864,253Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage2020 10,100,096Tissue protective peptides and uses thereof2018 9,580,465'Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage'2017 9,340,598'Tissue protective peptides and uses thereof'2016 8,853,358'Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage'2014 8,716,245'Tissue protective peptides and uses thereof'2014 8,673,861'Tissue protective peptides and uses thereof'2014 8,404,226'Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs'2013 8,071,554'Tissue protective peptides and uses thereof'2011 7,767,643'Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs'2010 7,718,363'Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds'2010 7,645,733'Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions'2010 7,410,941'Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin'2008 7,345,019'Modulation of excitable tissue function by peripherally administered erythropoietin'2008 7,309,687'Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin'2007 6,713,050'Method and composition for rejuvenating hairs, nails, tissues, cells and organs by ex-vivo or immersive treatment'2004 6,531,121'Protection and enhancement of erythropoietin-responsive cells, tissues and organs'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2013Patents assigned to KENNETH S WARREN INST INC (8)· patent assignee history

2003–2020Based in Woodbridge, CT, US· patent location history

2011–2020Patents assigned to ARAIM PHARMACEUTICALS INC (8)· patent assignee history

2011–2014Patents assigned to BRINES MICHAEL (5)· patent assignee history

2011–2014Patents assigned to CERAMI ANTHONY (5)· patent assignee history

2014Patents assigned to COLEMAN THOMAS (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ARAIM PHARMACEUTICALS INC	8	2011–2020
KENNETH S WARREN INST INC	8	2003–2013
BRINES MICHAELself	5	2011–2014
CERAMI ANTHONY	5	2011–2014
COLEMAN THOMAS	2	2014

Locations

Location	Patents	Span
Woodbridge, CT, US	17	2003–2020